Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ImmunityBio Inc.

    NASDAQ: IBRX · Real-Time Price · USD
    2.58
    -0.13 (-4.80%)
    At close: Aug 15, 2025, 2:33 PM

    ImmunityBio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 14.74M 622K 240K 934K
    Cost of Revenue
    		 n/a n/a 24.19M n/a
    Gross Profit
    		 14.74M 622K -23.95M 934K
    Operating Income
    		 -344.18M -362.25M -351.3M -330.28M
    Interest Income
    		 2.4M 863K 2.71M 836K
    Pretax Income
    		 -413.56M -583.89M -417.29M -349.84M
    Net Income
    		 -413.56M -583.2M -417.32M -349.85M
    Selling & General & Admin
    		 168.78M 129.62M 102.71M 135.26M
    Research & Development
    		 190.14M 232.37M 248.15M 195.96M
    Other Expenses
    		 n/a 886K -736K 193K
    Operating Expenses
    		 358.93M 362.87M 350.86M 331.21M
    Interest Expense
    		 154.33M 129.2M 63.52M 14.85M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 358.93M 362.87M 350.86M 331.21M
    Income Tax Expense
    		 81K -40K 34K 9K
    Shares Outstanding (Basic)
    		 697.31M 508.64M 399.9M 389.23M
    Shares Outstanding (Diluted)
    		 700.44M 508.64M 399.9M 389.23M
    EPS (Basic)
    		 -0.59 -1.15 -1.04 -0.9
    EPS (Diluted)
    		 -0.62 -1.15 -1.04 -0.9
    EBITDA
    		 -241.76M -436.18M -335.51M -315.38M
    EBIT
    		 -259.32M -454.69M -353.77M -334.99M
    Depreciation & Amortization
    		 17.55M 18.51M 24.19M 19.12M

    Add to Watchlist